0.08 (-124.30%)
As of Mar 06, 2023
Source:
Rubius Therapeutics, Inc is a biopharmaceutical company that has developed a platform and pipeline focused on creating an entirely new class of cellular medicines called Red Cell Therapeutics, or RCTs, for the treatment of cancer and autoimmune diseases.
Country | United States |
Headquarters | foxboro, massachusetts |
Phone Number | 617-679-9600 |
Industry | manufacturing |
CEO | Dannielle Appelhans |
Website | rubiustx.com |